Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
Agreement will see partners develop SARS-CoV-2 neutralising monoclonal antibodies
Read More
Tag: IAVI
MSD unveils bid to tackle coronavirus pandemic
The group will work on two experimental vaccines and an antiviral
Read More
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
- AstraZeneca wins US approval for first‑in‑class Baxfendy in hypertension
- Cellbxhealth partners with AdventHealth on CTC‑based monitoring in two major cancer studies
